Ireland's Elan has altered its licensing agreement with Roche to
give the Swiss firm expanded access to a technology designed to
improve the performance of drugs.
A widely used drug to treat breast cancer has been significantly
improved by the use of a new technology that binds it to albumin, a
common constituent of human blood.
Japanese pharmaceutical company, Takeda, has entered into
collaboration with Bionumerik Pharmaceuticals, with the intention
of marketing Bionumerik's Tavocept (dimensa), a chemoprotective
drug that relieves the neurotherapy commonly...
Cancer treatment to kill tumours could be made more effective by a
revolutionary approach to angiogenesis which takes the unusual
approach of opening up the tumour blood supply allowing better
access for cancer drugs and more effective...
Pharmaceutical companies seeking to design more effective
chemotherapy drugs will be encouraged by the latest discovery that
has isolated the independent mechanisms of action of two anticancer
drugs. This revelation provides drug...
Researchers in the US have developed a drug delivery technology
that could improve the treatment of cancer, avoid side effects and
even report back on the success of treatment.
Inhibitors of the enzyme histone deacetylase (HDAC) have entered
clinical testing in cancer, but may also prevent a serious and
life-threatening complication of bone marrow transplants.
A closed system that prevents the exposure of healthcare workers to
hazardous anticancer drugs, developed by Sweden's Carmel Pharma,
has been introduced in the USA by Baxa.